Read More Pharma Industry News Samsung Bioepis partners with C-Bridge Capital to expand biosimilar portfolio in China Samsung Bioepis, a South Korean leader in biopharmaceuticals, has struck a deal with private equity firm C-Bridge Capital… bypharmanewsdailyFebruary 11, 2019